Objective: To compare the HIV-related ocular manifestations between HAART-naïve (Highly active antiretroviral therapy) and HAART-treated patients. Study Design: Observational (comparative) Study. Place and Duration of the Study: Department of Ophthalmology and Family Care Centre of Hayatabad Medical Complex, Peshawar, Pakistan, from October 2019 to July 2021. Methodology: HIV-infected patients, who were receiving HAART treatment as well as HAART-naïve, were recruited. A complete ocular examination was performed to check for HIV-related ocular manifestations. Anterior and posterior segment ndings were recorded and compared between the two groups. Results: Of the 80 participants (40 in each group), 62 (77.5%) were males and 18 (22.5) were females with no signi cant di erence between the groups for either gender (p=1.0). A signi cant di erence, between the two groups, was found in the mean duration (838.64 + 908.16 days) of HIV infection at the time of recruitment (p<0.001). HIV-related ocular manifestations were found in 6 (7.5%) with no statistically signi cant di erence between the two groups (p=1.0). Similarly, the involvement of systemic co-infections was found in 6 (7.5%) with no statistically signi cant di erence between the group (p=0.675). Conclusion: There was no di erence in both groups when analysed for HIV-related ocular manifestations or systemic co-infections. The authors nding contradict with some of the previously published data. Therefore, it is recommended that further research should be carried out to reach de nite conclusion.